SEC CIK 1752014
Pfeil Keith W
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| GMEDview stock → | 5,833 | 2025-01-10 |
Position History — GMED
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — GMED
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-01-21 | Grant / award (derivative) | 100,000 | $0.00 | 100,000 |
| 2025-07-18 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2025-01-23 | Grant / award (derivative) | 60,000 | $0.00 | 60,000 |
| 2025-01-10 | Option exercise (derivative) | 5,833 | $0.00 | 0 |
| 2025-01-10 | Option exercise (derivative) | 8,334 | $0.00 | 833 |
| 2025-01-10 | Option exercise | 5,833 | $49.65 | 5,833 |
| 2025-01-10 | Open-market sale | 12,501 | $88.17 | 1,666 |
| 2025-01-10 | Open-market sale | 1,666 | $89.17 | 0 |
| 2025-01-10 | Option exercise | 8,334 | $53.27 | 14,167 |
| 2024-01-26 | Grant / award (derivative) | 60,000 | $0.00 | 60,000 |
| 2023-10-10 | Grant / award (derivative) | 5,000 | $0.00 | 5,000 |
| 2023-02-02 | Option exercise (derivative) | 15,000 | $0.00 | 9,167 |
| 2023-02-02 | Option exercise (derivative) | 14,167 | $0.00 | 5,833 |
| 2023-02-02 | Open-market sale | 29,167 | $77.57 | 0 |
| 2023-02-02 | Option exercise | 15,000 | $53.27 | 29,167 |
| 2023-02-02 | Option exercise | 14,167 | $49.65 | 14,167 |
| 2023-01-26 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2022-01-27 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2021-08-19 | Option exercise (derivative) | 833 | $0.00 | 23,334 |
| 2021-08-19 | Option exercise | 833 | $53.27 | 833 |
| 2021-08-19 | Open-market sale | 833 | $76.13 | 0 |
| 2021-08-19 | Option exercise (derivative) | 0 | $0.00 | 24,167 |
| 2021-08-19 | Option exercise (derivative) | 833 | $0.00 | 20,000 |
| 2021-08-19 | Open-market sale | 833 | $76.13 | 0 |
| 2021-08-19 | Option exercise | 833 | $49.65 | 833 |
| 2021-08-02 | Option exercise (derivative) | 833 | $0.00 | 24,167 |
| 2021-08-02 | Open-market sale | 833 | $83.24 | 0 |
| 2021-08-02 | Option exercise | 833 | $53.27 | 833 |
| 2021-07-19 | Option exercise (derivative) | 834 | $0.00 | 20,833 |
| 2021-07-19 | Open-market sale | 834 | $78.25 | 0 |
| 2021-07-19 | Option exercise | 834 | $49.65 | 834 |
| 2021-07-01 | Option exercise (derivative) | 833 | $0.00 | 25,000 |
| 2021-07-01 | Open-market sale | 833 | $77.43 | 0 |
| 2021-07-01 | Option exercise | 833 | $53.27 | 833 |
| 2021-06-25 | Option exercise (derivative) | 13,312 | $0.00 | 21,667 |
| 2021-06-25 | Option exercise (derivative) | 14,167 | $0.00 | 25,833 |
| 2021-06-25 | Option exercise | 14,167 | $53.27 | 14,167 |
| 2021-06-25 | Open-market sale | 27,479 | $75.04 | 0 |
| 2021-06-25 | Option exercise | 13,312 | $49.65 | 13,312 |
| 2021-05-05 | Option exercise (derivative) | 5,021 | $0.00 | 34,979 |
| 2021-05-05 | Option exercise | 5,021 | $49.65 | 5,021 |
| 2021-05-05 | Open-market sale | 5,021 | $75.00 | 0 |
| 2021-01-14 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2020-01-22 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2019-09-03 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2019-08-19 | — | — | — | 0 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.